Mumbai, Feb 09: Pharma major Lupin announced the launch of its Clonidine Hydrochloride extended-release tablets, 0.1mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin’s Clonidine Hydrochloride ER tablets is the generic equivalent of Concordia International Corp’s Kapvay tablets. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD)as monotherapy or as adjunctive therapy to stimulant medications.
Kapvay tablets had annual sales of approximately USD 66 million in
the US (IQVIA MAT December 2017).
